(Q60168790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

0 references

1 reference

corrigendum / erratum

Correction to: Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4

0 references

author

Maria Giovanna Francipane

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Patrizia Cammareri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Flora Iovino

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Anna Barbara Di Stefano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Antonino Agrusa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Gerolama Condorelli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

M Todaro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Y Lombardo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M Perez Alea

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

C Di Bernardo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

H Walczak

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

G Stassi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

18 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

762-772

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4402305

1 January 2020

exact match

0 references

cites work

Dysregulation of apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

The biochemistry of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Biochemistry and function of the DISC

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Targeting multiple arms of the apoptotic regulatory machinery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Th1 and Th2 cytokine response patterns in leukocyte cultures of patients with urinary bladder, renal cell and prostate carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Interleukin 4 therapy for patients with chronic lymphocytic leukaemia: a phase I/II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

TRAIL death receptors and cancer therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

CD4+ T-cell subsets in autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402305

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4402305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18202702%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference